首页 › 基金 › Aequim Alternative Investments LP › LGND

Aequim Alternative Investments LP 对 LGND 的持仓历史

LIGAND PHARMACEUTICALS INC · 医疗保健

Aequim Alternative Investments LP 在 Q3 2026 的 13F 申报中披露持有 LGND(LIGAND PHARMACEUTICALS INC)12,500,000 股,市值约 US$21.0M,约占其申报组合的 0.42%,在其申报持仓中市值排名第 45 位。 Aequim Alternative Investments LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)12.50M 股
申报持仓市值$21.01M
组合权重0.42%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Aequim Alternative Investments LP 对 LGND 的持仓演变

Aequim Alternative Investments LP 于 Q3 2026 首次披露 LGND 持仓:12,500,000 股(约 US$21.0M)。

逐季持仓明细

季度股数金额变化
Q3 2026 12.50M $21.01M 新进

关于 LGND 与 13F 数据

LGND(LIGAND PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 52 只申报持有 LGND,申报仓位最大的包括:CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 LGND 的基金

查看 LGND 的全部基金持有人 →

常见问题

How long has Aequim Alternative Investments LP held LGND?

Aequim Alternative Investments LP has disclosed LGND holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Aequim Alternative Investments LP's current position in LGND?

As of Q3 2026, Aequim Alternative Investments LP holds 12.50M shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $21.01M, representing 0.42% of its reported portfolio and ranking #45.

Has Aequim Alternative Investments LP been buying or selling LGND?

In the latest 13F filing (Q3 2026), Aequim Alternative Investments LP newly opened its position in LGND.

Which other funds hold LGND?

Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.